Gilead Sciences News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

28.04.16	EARNINGS SUMMARY: Details of Gilead Sciences Inc. Q1 Earnings Report (RTTNews)
15.04.16	Gilead Sciences' Two Phase 3 Studies On Tenofovir Meet Endpoints (RTTNews)
05.04.16	CYTR Awaits Data In June, GILD Gets FDA Nod, PGNX Will Have To Wait (RTTNews)
03.04.16	Biotech Stocks Facing FDA Decision In April (RTTNews)
31.03.16	Gilead Submits NDA In Japan For Tenofovir Alafenamide For Chronic HBV Patients (RTTNews)
25.03.16	Gilead To Pay $200 Mln To Merck, Ionis Pharma In Hepatitis C Drug Patent Suit (RTTNews)
23.03.16	Ionis And Merck Receive Positive Verdict On Gilead HCV Drug Patent Case (RTTNews)
02.03.16	AERI Awaits Data In Q3, FDA Approves Another TAF-based HIV Drug, CTIX On Watch (RTTNews)
17.02.16	FLXN Flexes Muscles, FDA Approves Broader Use Of Harvoni, Headache For TNXP (RTTNews)
16.02.16	Gilead: FDA Oks Two Supplemental Indications For Harvoni (RTTNews)
08.02.16	Capital Management Owns $9.982 Mln Worth Stake In Gilead Sciences (RTTNews)
03.02.16	Earnings Reported After The Bell Feb. 2 (RTTNews)
02.02.16	Gilead Sciences Raises Dividend; Announces $12 Bln Buyback Program (RTTNews)
02.02.16	Gilead Sciences Inc. Q4 Earnings Rise 26% (RTTNews)
29.01.16	Gilead Names CEO Martin As Executive Chairman; Milligan Promoted To CEO (RTTNews)
19.01.16	Gilead Now Owns 14.75% Of Galapagos' Outstanding Share Capital - Quick Facts (RTTNews)
13.01.16	Galapagos, Gilead Cleared By U.S. FTC To Close Global Partnership On Filgotinib (RTTNews)
12.01.16	Gilead Submits NDA For Tenofovir Alafenamide - Quick Facts (RTTNews)
07.01.16	Mylan Pharma Launches Generic Harvoni In India - Quick Facts (RTTNews)
06.01.16	GILD Quits IPF Study, PURE On Watch, Black Letter Day For MNKD, CNAT Leaps (RTTNews)
06.01.16	Gilead Sciences Terminates Phase 2 Study Of Simtuzumab In Patients With IPF (RTTNews)
05.01.16	Gilead Says Two Phase 3 Trials On Tenofovir Alafenamide Met Primary Objectives (RTTNews)
05.01.16	EXEL Shines On Meteor Impact, GILD Gets FDA Date, VCEL Moving Ahead (RTTNews)
05.01.16	Gilead Announces FDA Priority Review Designation For Sofosbuvir/Velpatasvir (RTTNews)
17.12.15	Galapagos And Gilead Collaborate On Global Development Of Filgotinib (RTTNews)
08.12.15	Gilead Sciences Reveals Postive Result For Zydelig Combination In Leukemia (RTTNews)
07.12.15	Gilead: Health Canada Issues Notice Of Compliance For Genvoya - Quick Facts (RTTNews)
04.12.15	Gilead: European Medicines Agency Validates Marketing Application For SOF/VEL (RTTNews)
23.11.15	EU Grants Marketing Authorization For Gilead's Genvoya To Treat HIV-1 Infection (RTTNews)
14.11.15	Gilead To Present Investigational Compounds For Hepatitis B And Liver Fibrosis (RTTNews)
13.11.15	Gilead's Hepatitis C Drug Approved For Expanded Use (RTTNews)
06.11.15	EYEG Catches Investors' Eyes, FDA Approves GILD's HIV Pill, KBIO Lays Off Staff (RTTNews)
06.11.15	FDA Oks Gilead's Single Tablet Regimen Genvoya For Treatment Of HIV-1 Infection (RTTNews)
29.10.15	GILD Files NDA For HCV Medicine, Canada Gets MonaLisa Touch, APRI Awaits Data (RTTNews)
27.10.15	Gilead Sciences Inc. Q3 Earnings Rise 61% (RTTNews)
22.10.15	Gilead Phase 3 Study Shows Genvoya Statistically Non-inferior To Stribild In HIV (RTTNews)
06.10.15	CTRV Grabs Headlines, Watch Out For EXAS Today, ONCE Gets A Spark (RTTNews)
05.10.15	Avita Back In News, GILD Gets FDA Thumbs Up, HZNP Settles Rayos Patent Suit (RTTNews)
25.09.15	European CHMP Adopts Positive Opinion For Gilead's Genvoya For HIV - Quick Facts (RTTNews)
21.09.15	Gilead Sciences Announces Results From Four Int'l Phase 3 Clinical Studies (RTTNews)
10.09.15	Gilead Sciences Prices $10 Bln Of Senior Unsecured Notes - Quick Facts (RTTNews)
02.09.15	Gilead's Fixed-Dose Combination Of F/TAF Meets Primary Goal In Phase 3 HIV Study (RTTNews)
21.08.15	Gilead Sciences' Third TAF-based Filing Under Review By EMA (RTTNews)
29.07.15	Pre-market Movers For July 29 (HLT, MO, GILD, TWTR, YELP) (RTTNews)
29.07.15	Gilead Sciences Q2 Profit Up 23%, Results Beat View; Lifts 2015 Sales Outlook (RTTNews)
29.07.15	After-market Movers For July 28 (RUBI, GILD, AKAM, TWTR, YELP) (RTTNews)
28.07.15	Gilead Sciences Q2 Profit Tops Estimates; Updates Full Year Guidance (RTTNews)
28.07.15	EARNINGS SUMMARY: Details of Gilead Sciences Inc. Q2 Earnings Report (RTTNews)
22.07.15	Da Vinci Brightens Up ISRG, HZNP Sweetens DEPO Bid, ISIS Earns A Milestone (RTTNews)
16.07.15	EC Approves Bristol-Myers' Evotaz To Treat HIV-1 Infection In Adults (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V

mehr

22.11.24		Dow Jones aktuell: Dow Jones zum Ende des Freitagshandels in der Gewinnzone
22.11.24		Gute Stimmung in Europa: Anleger lassen STOXX 50 letztendlich steigen
22.11.24		Freundlicher Handel: Börsianer lassen SPI schlussendlich steigen
22.11.24		Pluszeichen in Zürich: SMI zum Ende des Freitagshandels mit grünem Vorzeichen
22.11.24		Zuversicht in London: FTSE 100 beendet die Freitagssitzung in der Gewinnzone
22.11.24		SIX-Handel: SLI zeigt sich zum Ende des Freitagshandels fester

22.11.24

Dow Jones aktuell: Dow Jones zum Ende des Freitagshandels in der Gewinnzone

22.11.24

Gute Stimmung in Europa: Anleger lassen STOXX 50 letztendlich steigen

22.11.24

Freundlicher Handel: Börsianer lassen SPI schlussendlich steigen

22.11.24

Pluszeichen in Zürich: SMI zum Ende des Freitagshandels mit grünem Vorzeichen

22.11.24

Zuversicht in London: FTSE 100 beendet die Freitagssitzung in der Gewinnzone

22.11.24

SIX-Handel: SLI zeigt sich zum Ende des Freitagshandels fester